Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS)
CNY 8.87
(2.31%)
CNY 8.87
(2.31%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 72.89 Million CNY | 18.54% |
| 2022 | 61.49 Million CNY | 4412.49% |
| 2021 | 1.36 Million CNY | 288.58% |
| 2020 | 350.71 Thousand CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | -100.0% |
| 2017 | 1.00 CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 90.55 Million CNY | 815.65% |
| 2024 Q1 | 9.94 Million CNY | -85.79% |
| 2024 Q2 | 9.89 Million CNY | -0.5% |
| 2023 Q3 | 71.37 Million CNY | 15.54% |
| 2023 Q4 | 72.89 Million CNY | 2.12% |
| 2023 FY | 72.89 Million CNY | 18.54% |
| 2023 Q1 | 62.22 Million CNY | 1.19% |
| 2023 Q2 | 61.77 Million CNY | -0.73% |
| 2022 Q4 | 61.49 Million CNY | -0.85% |
| 2022 Q3 | 62.02 Million CNY | -0.69% |
| 2022 Q2 | 62.44 Million CNY | 18.75% |
| 2022 FY | 61.49 Million CNY | 4412.49% |
| 2022 Q1 | 52.58 Million CNY | 3758.81% |
| 2021 Q4 | 1.36 Million CNY | 184.4% |
| 2021 Q3 | 479.18 Thousand CNY | -37.21% |
| 2021 Q2 | 763.15 Thousand CNY | -76.26% |
| 2021 Q1 | 3.21 Million CNY | 816.63% |
| 2021 FY | 1.36 Million CNY | 288.58% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 FY | 350.71 Thousand CNY | 0.0% |
| 2020 Q4 | 350.71 Thousand CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q2 | 1.00 CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | -100.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |